JPS6361954A - Method and apparatus for preparing sample liquid for analysis - Google Patents

Method and apparatus for preparing sample liquid for analysis

Info

Publication number
JPS6361954A
JPS6361954A JP20701086A JP20701086A JPS6361954A JP S6361954 A JPS6361954 A JP S6361954A JP 20701086 A JP20701086 A JP 20701086A JP 20701086 A JP20701086 A JP 20701086A JP S6361954 A JPS6361954 A JP S6361954A
Authority
JP
Japan
Prior art keywords
nozzle
liquid
well
microplate
dilution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP20701086A
Other languages
Japanese (ja)
Inventor
Shigeki Akamatsu
赤松 繁樹
Kenichi Iwase
健一 岩瀬
Yoshikazu Furuya
古谷 義和
Hisashi Motokawa
久志 本川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KOKUSAI SHIYAKU KK
Teramecs Co Ltd
Original Assignee
KOKUSAI SHIYAKU KK
Teramecs Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KOKUSAI SHIYAKU KK, Teramecs Co Ltd filed Critical KOKUSAI SHIYAKU KK
Priority to JP20701086A priority Critical patent/JPS6361954A/en
Publication of JPS6361954A publication Critical patent/JPS6361954A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To easily, surely and exactly complete a dilution system for a liquid to be examined by executing the dispensing, mixing and dilution of a diluting liquid with the same implements;. i.e., nozzles. CONSTITUTION:A slide base part 1 consists of a slide base 9, a pulse motor 10 for moving the base 9 back and force between prescribed positions, a belt 11 and a position detecting means 12. A nozzle section 2 moves the nozzles 13 upward and downward and to execute the suction and discharge of liquid. A suction and discharge pump section 3 consists of plural plunger pumps 19- connected via nozzle tubes to the respective nozzles 13- and a motor 20 and transmission means 21 to drive the pumps 19. An operation section 4 is provided with keys 22-25 for assigning the modes to instruct the actions of the respective stages, keys 26-30 for selecting items, a main switch 31, etc., and the operations thereof are checked and displayed on a display part 5. A memory and control section 6 consists of a CPU41 and outputs operation commands to the respective sections 1-3, 5 upon receipt of the input instructions from the operation section 4.

Description

【発明の詳細な説明】 〔技術分野〕 本発明は、例えばウィルス感染症や悪性腫瘍の診断の為
の赤血球凝集反応に基づく検査とか、ラテックスやマイ
クロパーティクルを用いる凝集反応を利用した各種臨床
検査に供するために、希釈系列化した試料液を正確且つ
簡便に調製する方法及び装置に関する。
[Detailed Description of the Invention] [Technical Field] The present invention is applicable to, for example, tests based on red blood cell agglutination reactions for diagnosing viral infections and malignant tumors, and various clinical tests using agglutination reactions using latex or microparticles. The present invention relates to a method and an apparatus for accurately and simply preparing a diluted sample solution for serving.

〔技術的背景〕[Technical background]

内外における人的交流や輸血・血液製剤注射の機会増大
等によるウィルス感染症の増加9人口の高齢化に伴う癌
腫瘍の発生率増加に対処するために、臨床的にこれらを
効率よく検査する技術の発展が望まれている。ところで
、これらに罹病しているか否かの判断のひとつに、ウィ
ルスや腫瘍に起因するある種の血中微量成分の抗原・抗
体反応による検出がある。
Increase in the number of viral infections due to increased opportunities for human interaction within and outside the country and increased opportunities for blood transfusions and blood product injections 9 Technology for efficiently clinically testing these diseases in order to cope with the increasing incidence of cancer tumors associated with the aging of the population. development is desired. By the way, one way to determine whether or not a person is suffering from these diseases is by detecting certain trace components in the blood caused by viruses or tumors through antigen-antibody reactions.

例えば、急性ウィルス感染症の一種であるB型肝炎は多
くのウィルス保有者がおり悪化すれば肝硬変や肝臓ガン
になる危険性があるが、現在では該ウィルスに関連する
抗原、抗体系(HBs、HBc、HBeの各抗原、抗体
)が良く知られており、その検出は臨床検査分野におい
て重要な位置を占めつつある。
For example, hepatitis B, which is a type of acute viral infection, has many virus carriers, and if it worsens, there is a risk of liver cirrhosis or liver cancer. HBc and HBe antigens and antibodies) are well known, and their detection is occupying an important position in the field of clinical testing.

この分析はPHA法(受身赤血球凝集反応)とかRPH
A法(逆受身赤血球凝集反応)により行なわれるもので
、被検液を希釈液(通常リン酸緩衝液を用いる)で段階
的に希釈(通常2のn乗倍列)した各試料液に或種の感
作赤血球を加え、或希釈段階(通常16倍或いは32倍
)での凝集の有無(スクリーニングテスト)とか、全希
釈系列での凝集程度を試薬を加えた系列の凝集程度と比
較する(確認試験)方法で行なわれ、感染の有無及び感
染患者の予後経過等を調べるものである。
This analysis is performed using the PHA method (passive hemagglutination reaction) or RPH method.
This is carried out using Method A (reverse passive hemagglutination reaction), in which the test solution is diluted stepwise (usually by 2 to the nth power) with a diluent (usually using a phosphate buffer) and a Add sensitized red blood cells of the species and check the presence or absence of agglutination at a certain dilution level (usually 16 times or 32 times) (screening test), or compare the degree of agglutination in the entire dilution series with the degree of agglutination in the series in which the reagent is added ( Confirmatory testing) is conducted to investigate the presence or absence of infection and the prognosis of infected patients.

〔従来技術及びその問題点〕 現在、上記試料液(希釈系列)の作成については、Ll
lIX12個のウェルを持つ規格化されたマイクロプレ
ートを用い、該ウェルにドロンパーやマイクロピペット
で希釈液を分注(通常25μl又は50μL)シ、被検
液の採取(通常25μ又は50μl)と攪拌混合及び希
釈を第5図に示す如きグイリュータ−(イ)を用いて行
なっている。
[Prior art and its problems] Currently, the preparation of the above sample solution (dilution series) is
Using a standardized microplate with 12 wells, dispense the diluted solution (usually 25 μl or 50 μl) into the wells with a dropper or micropipette, collect the test solution (usually 25 μl or 50 μl), and mix by stirring. The dilution is carried out using a guilureator (a) as shown in FIG.

(従来技術の欠点) しかし、従来法には種々な欠点がある。まず第一に、希
釈液の分注と被検液の採取、攪拌・希釈が異なった用具
(ドロンパーとグイリュータ−)により行なわれるため
、誤差を生じ易い。
(Disadvantages of Prior Art) However, the conventional method has various drawbacks. First of all, since the dispensing of the diluent and the collection, stirring and dilution of the test liquid are performed using different tools (dromper and guilter), errors are likely to occur.

またグイリュータ−(イ)は、棒状本体(ロ)の先端に
切込み部(ハ)を設けたもので、この切込み部(ハ)に
毛管現象で被検液或いは混合希釈液を保持する構成をと
る。切込み部(ハ)に溜った液は、攪拌時の回転により
飛び出す。従って、■使用に熟練が必要で、持込量と持
ち出し量が一定になりにり<、個人差も大きいとか、■
血清は希釈液に比べて粘度が高いため希釈により粘度が
変化し希釈倍率が上がる程算定希釈率との差が大になる
とか、0表面や切込み部の汚れにより濡れの程度が異な
るため保持量が経時的に変化するので、定期的に不純物
を焼却除去する必要があるし、プレウエッテングや使用
後の洗浄・濾紙による水分除去等の手入れ作業が必要で
手間がかかるとか、■チタン合金性故高価であるし、極
めて硬くウェル壁を疵付けて凝集反応に影響を与えると
か、■容量一定故、希釈率は当初の緩衝液と被検液の割
合により決り変更できない等、多くの問題点を有してい
る。
In addition, the Guilyutor (A) has a notch (C) at the tip of the rod-shaped body (B), and is configured to hold the test liquid or mixed diluted liquid in this notch (C) by capillary action. . The liquid that has accumulated in the notch (c) will fly out due to the rotation during stirring. Therefore, ■It requires skill to use, the amount brought in and the amount taken out is constant, and there are large individual differences.■
Serum has a higher viscosity than a diluted liquid, so the viscosity changes with dilution, and the higher the dilution rate, the greater the difference from the calculated dilution rate, and the degree of wetting varies depending on the dirt on the surface and cut, so the amount retained may vary. As the impurities change over time, it is necessary to periodically incinerate and remove impurities, and maintenance work such as pre-wetting, washing after use, and removing moisture with filter paper is required, which is time-consuming. There are many problems such as it is expensive, it is extremely hard and can damage the well wall and affect the agglutination reaction, and because the volume is constant, the dilution rate is determined by the initial ratio of buffer solution and test solution and cannot be changed. have.

C本発明の目的〕 本発明は上記に鑑み、被検液の性状や検査者の熟練程度
等により影響を受けず、簡単、確実且つ正確に被検液の
希釈系列を完成することを目的とする。また、希釈倍率
を簡単に変更できる試料液の調製方法を提供することを
目的とする。更に、操作や手入れが簡単で確実に作動し
、構造が簡単で安価に得られる試料液の調製装置を提供
することを目的とする。
C. Purpose of the present invention In view of the above, the present invention aims to easily, reliably, and accurately complete a dilution series of a test solution without being affected by the properties of the test solution or the level of skill of the examiner. do. Another object of the present invention is to provide a method for preparing a sample liquid in which the dilution ratio can be easily changed. Another object of the present invention is to provide a sample liquid preparation device that is easy to operate and maintain, operates reliably, has a simple structure, and can be obtained at low cost.

これらの目的は、ドロンパーとグイリュータ−の組合せ
に代えて、希釈液の分注とミキシング及びグイリュージ
ョンを同一の用具即ちノズルで行なうことにより達成さ
れる。このノズルはチューブを介してプランジャーポン
プやチューブポンプ等微小量を正確に吸排するポンプに
連結されており、マイクロコンピュータ−で制御される
These objectives are achieved by performing the dispensing and mixing of the diluent and the guillusion with the same device or nozzle, instead of a combination of dromper and guilluter. This nozzle is connected via a tube to a pump such as a plunger pump or a tube pump that sucks and discharges minute amounts accurately, and is controlled by a microcomputer.

〔実施例〕〔Example〕

以下、本発明をPHA法を例にとり図面に示す実施例に
基づいて詳細に説明する。
Hereinafter, the present invention will be explained in detail by taking the PHA method as an example and based on embodiments shown in the drawings.

第1図〜第3図は、本発明方法を具現化した試材部調製
装置の一例で、第1図は機械的主要部分の構成図、第2
図は全体のブロック図、第3図は流路図である。
Figures 1 to 3 show an example of a sample preparation device that embodies the method of the present invention; Figure 1 is a configuration diagram of the main mechanical parts;
The figure is an overall block diagram, and FIG. 3 is a flow path diagram.

(構造) この装置は、スライドベース部(1)、ノズル部(2)
(Structure) This device consists of a slide base part (1), a nozzle part (2)
.

吸排ポンプ部(3)、操作部(4)2表示部(5)及び
記憶・制御部(6)から構成される。
It is composed of a suction/discharge pump section (3), an operation section (4), a display section (5), and a storage/control section (6).

スライドベース部(1)は、マイクロプレート(7)や
緩tE液容器(8)を所定位置に載置するスライドベー
ス(9)と、該スライドベース(9)を所定位置間で往
復動させる駆動源としてのパルスモータ(10)、伝達
手段としてのベル)(11)及び位置検出手段(12)
からなる。位置検出手段(12)は、例えばホトカプラ
ーと邪魔板よりなる。スライドベース(9)上には被検
液や血球試薬(共に図示路)を載置するスペースを設け
てもよいし、ベルト(11)の代わりにラックとピニオ
ンを用いてもよい。
The slide base part (1) includes a slide base (9) on which a microplate (7) and a slow tE liquid container (8) are placed in a predetermined position, and a drive that reciprocates the slide base (9) between predetermined positions. a pulse motor (10) as a source, a bell (11) as a transmission means and a position detection means (12)
Consisting of The position detection means (12) includes, for example, a photocoupler and a baffle plate. A space may be provided on the slide base (9) to place a test liquid and a blood cell reagent (both paths shown), and a rack and pinion may be used instead of the belt (11).

ノズル部(2)は、ノズル(13)を上下動させるとと
もに液体の吸引・吐出を行わせるもので、本例で(ま8
(固くまたは12(固、マイクロプレートト(7)の構
造によっては10個)のノズル(13)・・・をノズル
ホルダー(14)で1列状態に支持し、該ノズルホルダ
ー(14)を支えるノズルアーム(15)をモータ(1
6)で回転する偏心カム(17)により上下動させる構
成をとる。尚、図中符号(42)は該偏心カムの定位置
を検出するための位置検出手段である。偏心カム(17
)に替えて、油圧シリンダーその他の手段でノズル(I
3)の上下動を行ってもよい。ノズル部(2)の作用に
より、マイクロプレート(7)の各ウェル(71)・・
・に希釈液(81)を分注したり、別途滴下する被検液
と緩衝液(81)の攪拌・希釈を行なう。被検液や血球
試薬の採取・滴下を行わせることもできる。
The nozzle part (2) moves the nozzle (13) up and down and sucks and discharges liquid.
(Hard or 12 (hard, 10 depending on the structure of the microplate (7)) nozzles (13)... are supported in a row by a nozzle holder (14), and the nozzle holder (14) is supported. Connect the nozzle arm (15) to the motor (1
6), it is configured to be moved up and down by an eccentric cam (17) that rotates. Incidentally, reference numeral (42) in the figure is a position detection means for detecting the normal position of the eccentric cam. Eccentric cam (17
) instead of the nozzle (I) using a hydraulic cylinder or other means.
The vertical movement of 3) may also be performed. By the action of the nozzle part (2), each well (71) of the microplate (7)...
- Dispense the diluent solution (81), or stir and dilute the test solution and buffer solution (81) that are dropped separately. It is also possible to collect and drip test fluids and blood cell reagents.

吸排ポンプ部(3)は、上記各ノズル(13)・・・に
ノズルチューブ(18)を介して連結される複数のプラ
ンジャーポンプ(19)・・・と、該プランジャーポン
プ(19)を駆動するモータ(パルスモータ’) (2
0)及びラック・ピニオンからなる伝達子l2(21)
よりなる。プランジャーポンプ(19)に代えてチュー
ブポンプを用いてもよいし、ランク・ピニオンに代えて
ベルトで駆動してもよい。図中、符号(43)はラック
ひいてはプランジャーポンプ(I9)の定位置を検出す
るための位置検出手段である。
The suction/discharge pump section (3) includes a plurality of plunger pumps (19) connected to each of the nozzles (13) through nozzle tubes (18), and the plunger pumps (19). Drive motor (pulse motor') (2
0) and a transmitter l2 (21) consisting of a rack and pinion.
It becomes more. A tube pump may be used instead of the plunger pump (19), and a belt may be used instead of the rank and pinion. In the figure, reference numeral (43) is a position detection means for detecting the normal position of the rack and thus the plunger pump (I9).

操作部(4)は、各工程(緩衝液の吸入・滴下、被検液
滴下後の攪拌・希釈、ノズル(13)の洗浄等)の作動
を指示するモード指定用のキー(22)・(23)・(
24)・(25)や、項目(希釈段数指定、初期倍率指
定等)選定のためのキー(26)・(27)・(28)
・(29)・(30)及びメインスイッチ(31)等を
備えており、この操作が表示部(5)に確認表示される
。符号(32)〜(40)が確認表示のためのLEDで
ある。
The operation unit (4) has mode designation keys (22) and ( 23)・(
24), (25), and keys for selecting items (number of dilution steps, initial magnification, etc.) (26), (27), (28)
・(29)・(30) and a main switch (31), etc., and this operation is displayed on the display section (5) for confirmation. Reference numerals (32) to (40) are LEDs for confirmation display.

記1、α・制御部(6)は、希釈その他のプログラムや
クロックを含むCPU(41)からなり、操作部(4)
からの入力指示を受けて各部(1)・(2)・(3)・
(5)に作動指令を出力する。本例では、ノズル(13
)による液体の吸引量(25μ乏、50μに)や希釈段
数(4段。
Note 1. The control unit (6) consists of a CPU (41) containing dilution and other programs and a clock, and the operation unit (4).
Each section receives input instructions from (1), (2), (3),
(5) Outputs the operation command. In this example, the nozzle (13
) and the amount of liquid aspirated (from 25μ to 50μ) and the number of dilution stages (4 stages.

8段、12段)、初期倍率(2倍、4倍)等は予め定め
であるが、これらを任意に変更設定できるようにプログ
ラムを組むこともできる。
8 steps, 12 steps), initial magnification (2x, 4x), etc. are predetermined, but a program can be created so that these can be changed and set as desired.

尚、上記例ではマイクロプレート(7)を載置するスラ
イドベース(9)を移動させる構造を採っているが、ノ
ズル部(2)をスライドベース等で支持し、マイクロプ
レート(7)等を固定する構造としてもよい。
In addition, in the above example, a structure is adopted in which the slide base (9) on which the microplate (7) is placed is moved, but it is also possible to support the nozzle part (2) with a slide base etc. and fix the microplate (7) etc. It is also possible to have a structure in which

(作動) 次に、図示の装置による試料液の調製方法を説明する。(operation) Next, a method for preparing a sample liquid using the illustrated apparatus will be explained.

まず、測定目的に合わせて操作部(4)で設定を行なう
。例えば、PHA法(受身赤血球凝集反応によるB型肝
炎のHB、e抗体測定)のスクリーニングテストでは、
8X12(固(10X12のものもある)のウェル(7
1)・・・を持つマイクロプレート(7)を睡或いは横
方向にセントし、1個の被検液に対し1列4個のウェル
(71)を使用する。これは、被検液を16倍(第1段
目ウェルでの希釈倍率2)或いは32倍(第1段目ウェ
ルでの希釈倍率4)に希釈した試料液が凝集するか否か
で陽性か陰性かを判断するものである。
First, settings are made using the operation section (4) according to the purpose of measurement. For example, in the PHA method (hepatitis B HB, e antibody measurement using passive hemagglutination reaction) screening test,
8x12 (solid (10x12 also available) wells (7
1) A microplate (7) with ... is placed horizontally or horizontally, and four wells (71) in one row are used for one test liquid. This is a positive test based on whether the sample solution diluted 16 times (dilution factor 2 in the first well) or 32 times (dilution factor 4 in the first well) aggregates. This is to determine whether the test is negative.

そして、メインスイッチ(31)を入れ選定キー(30
)で4段使用(LED(33)点灯)1選定キー(27
)で1〜4番目のウェル(71)使用(L E D (
35)点灯)。
Then, turn on the main switch (31) and select key (30).
) is used in 4 stages (LED (33) lights up) 1 selection key (27
), use the 1st to 4th wells (71) (L E D (
35) lit).

選定キー(26)で初期倍率2(LED(32)点灯)
を夫々選定する。次いで新しいマイクロプレート(7)
をスライドベース(9)の所定位置に位置固定し、モー
ド指定キー(ドロッパー・緩衝液注入)(22)を押す
。するとスライドベース(9)がノズル部(2)方向に
移動し、ノズル(13)の翼下に緩衝液容器(8)の緩
衝液(81)がくる位置で一時停止する。この停止位置
は、位置検出手段(I2)で検出される定位置からのパ
ルス数で制御する。この状態でノズル(13)先端が下
がって所定量(25μ)の緩衝液(81)を吸入して上
昇する。次いで、第1段目のウェル(7I)の位置にノ
ズル(13)が来るようにスライドベース(9)が反対
方向に移動して停止した後ノズル(13)が下降し、同
−段にある全てのウェル(7I)内にBtE液(81)
を吐出(分注)する。同様の操作を繰り返し第2〜第4
段目の各ウェル(7I)にも緩衝液(81)を25μ乏
ずつ分注する。緩衝液(81)としては通常リン酸緩衝
液を用いる。
Initial magnification 2 (LED (32) lights up) with selection key (26)
Select each. Next, a new microplate (7)
is fixed at a predetermined position on the slide base (9), and press the mode designation key (dropper/buffer injection) (22). Then, the slide base (9) moves toward the nozzle part (2) and temporarily stops at a position where the buffer solution (81) of the buffer solution container (8) comes under the wings of the nozzle (13). This stop position is controlled by the number of pulses from the home position detected by the position detection means (I2). In this state, the tip of the nozzle (13) is lowered, sucks in a predetermined amount (25μ) of the buffer solution (81), and rises. Next, the slide base (9) moves in the opposite direction so that the nozzle (13) comes to the position of the well (7I) in the first stage, and after stopping, the nozzle (13) descends and is located in the same stage. BtE solution (81) in all wells (7I)
Dispense (dispense). Repeat the same operation for 2nd to 4th
25μ of the buffer solution (81) is also dispensed into each well (7I) of the row. A phosphate buffer is usually used as the buffer (81).

次いで、第1段目の各ウェル(71)に夫々異なる被検
液を、別途マイクロピペット等で25誠ずつ注入した後
、モード指定キー(23)  (攪拌・希釈用)を押す
。すると、ノズル(13)が第1段目のウェル(71)
の位置で上下動しつつ吸入・吐出を数回繰り返す。この
操作により被検液と緩衝液(81)が均一に攪拌される
。(この際の吸入量を25μlにしておくと作動指令が
簡単?こなる。)この状態で確実に2倍希釈された第1
の試料液が50pl得られる。
Next, after separately injecting 25 centimeters of a different test solution into each well (71) in the first stage using a micropipette, press the mode designation key (23) (for stirring/dilution). Then, the nozzle (13) enters the first stage well (71).
Repeat inhalation and exhalation several times while moving up and down at this position. By this operation, the test liquid and the buffer solution (81) are uniformly stirred. (If the inhalation amount at this time is 25 μl, the operation command will be easier.) In this state, make sure that the first sample is diluted twice.
50 pl of sample solution is obtained.

最後にこの希釈された液を25μl吸引したまま上昇し
、第2段目のウェル(71)をノズル(13)の真下に
移動させ、ここで該希釈された25μ夕の液を吐出し、
同様に吸入・吐出を繰り返して攪拌し4倍希釈の試料液
を得る。同様にして、第4段目のウェル(71)では1
6倍に希釈された試料液が50μl得られる。その内2
5バを吸引し、緩衝液容器(8)の廃液入れ(84)に
排出する。
Finally, 25μl of this diluted liquid is sucked up and the second stage well (71) is moved to just below the nozzle (13), where 25μl of the diluted liquid is discharged.
Similarly, inhale and exhale are repeated and stirred to obtain a 4-fold diluted sample solution. Similarly, in the fourth well (71), 1
50 μl of a 6-fold diluted sample solution is obtained. 2 of them
5 is aspirated and drained into the waste container (84) of the buffer container (8).

以上で、各4個のウェルに4′@に希釈された試料液が
25μiずつ充虜されたことになり、希釈操作(試料液
調整)が完了する。
With the above steps, each of the four wells is filled with 25 .mu.i of the sample solution diluted to 4'@, and the dilution operation (sample solution adjustment) is completed.

その後、非特異反応吸収のため37度で1時間程度イン
キュベートし、次いで第4段目のウェル(7I)に、H
BeAg感作ヒツジ赤血球(商品名:e−セル、国際試
薬側製)にリン酸緩衝液を加えた懸濁液の25μえをマ
イクロピペットで採取して加え、10秒程度震盪混和す
る。しかる後、37度で3時間以上インキュベートし、
凝集像を観察する。判定は、陰性コントロールの凝集像
と比較して行なう。陰性コントロールは通常緩衝液を用
い、マイクロプレート(7)のいずれかの1列4個のウ
ェル(71)に25μlずつ入れておき、同様に血球試
薬(感作血球懸濁液)を加えたものである。
After that, incubate at 37 degrees for about 1 hour to absorb non-specific reactions, and then add H to the fourth well (7I).
A 25 μm sample of a suspension of BeAg-sensitized sheep red blood cells (trade name: e-cell, manufactured by Kokusai Reagents) in phosphate buffer is collected with a micropipette, added, and shaken for about 10 seconds to mix. After that, incubate at 37 degrees for more than 3 hours,
Observe the aggregate image. Judgment is made by comparing with the agglutination image of a negative control. For the negative control, use a normal buffer solution, put 25 μl into each row of 4 wells (71) in any one of the microplates (7), and add the blood cell reagent (sensitized blood cell suspension) in the same way. It is.

任意の時点でモード指定キー(25) (洗浄用)を押
すと、ノズル(13)の真下に緩衝液容器(8)の洗浄
液入れ(82)または(83)がくるので、ここで洗浄
液を吸引し廃液入れ(84)に排出してノズルチップの
洗浄を行なう。尚、他のモードの最後の段階でも自動的
にノズル(I3)の洗浄を行なう。またモード指定キー
(24)は被検液採取のためのもので、このキーを備え
ておくと、別途スライドベース(9)上に多穴の?、!
!!検液容器(図示略)を載置し、手動に替えて各被検
液をノズル(13)で吸引して第1段目のウェル(71
)に注入することができる。
If you press the mode designation key (25) (for cleaning) at any time, the cleaning solution container (82) or (83) of the buffer container (8) will come directly below the nozzle (13), so you can aspirate the cleaning solution here. The nozzle tip is cleaned by discharging it into a waste liquid container (84). Note that the nozzle (I3) is also automatically cleaned at the final stage of other modes. In addition, the mode designation key (24) is for collecting the sample liquid, and if you have this key, you can use the multi-hole mode selection key (24) on the slide base (9). ,!
! ! A test liquid container (not shown) is placed there, and each test liquid is suctioned into the first well (71) using the nozzle (13) instead of manually.
) can be injected.

また前記例では、1〜4段目のウェル(71)のみを用
いたが、被検液の数によっては選定キー(28)及び(
29)を操作して、5〜8段目(L E D (36)
点灯)、9〜12段目(LED(37)点灯)を同様に
用いることもできる。この場合も、選定キー(30)を
押して4段使用(LED(38)点灯)とする。ノズル
部(2)やスライドベース部(1)等の動きは1段目・
5段目・9段目が同じ動きになる。更に、各機の採取量
を50μtにする場合は、選定キー(26)を操作して
50μ乏法(LED(34)点灯:第1段目は2倍希釈
)を採用するとよい。
Further, in the above example, only the first to fourth wells (71) were used, but depending on the number of test liquids, the selection key (28) and (
29) to move to the 5th to 8th rows (L E D (36)
(LED (37) lit) and the 9th to 12th stages (LED (37) lit) can also be used in the same way. In this case as well, press the selection key (30) to use 4 stages (LED (38) lights up). The movement of the nozzle part (2), slide base part (1), etc. is the first stage.
The 5th and 9th steps have the same movement. Furthermore, if the amount to be collected from each machine is 50 μt, it is preferable to operate the selection key (26) and adopt the 50 μ-poor method (LED (34) lights up: 1st stage is 2-fold dilution).

測定を32倍希釈した試料液で行なうには、選定キー(
2G)を操作してL E D (33)を点灯させる。
To perform a measurement using a sample solution diluted 32 times, press the selection key (
2G) to turn on the LED (33).

かくすると、第1段目のウェル(71)に緩衝液(81
)を75μ之、他のウェル(71)には25度ずつ分注
する指令をだす。上記75成は、25μlずつ3回行な
うようにしてもよいが、−度で行なわせることもできる
。被検液は同じ(25μl故、第1段目で4倍に希釈さ
れたものが100成得られるので、その半分の50μt
を廃棄するとその後は前記例同様に扱える。
In this way, the buffer solution (81) is placed in the first stage well (71).
) to the other wells (71) at 25° intervals. The above-mentioned 75 formation may be carried out three times with each 25 μl, but it can also be carried out at -degrees. The test solution is the same (25 μl, so 100 samples are obtained by diluting it 4 times in the first stage, so 50 μt, which is half of that amount)
After discarding , you can handle it in the same way as in the previous example.

次に、同様にPHA法による確認試験について説明する
。確認試験は、スクリーニングで陽性或いは擬陽性と判
定された被検液についてより精細に行なうもので、1被
検液について8段(8穴)のウェル(71)を2系列使
用する。陽性及び陰性コントロールも同様に各8段1系
列使用する。8段目の希釈倍率を256にするには1段
目を2倍、512倍にするには1段目を4倍希釈する。
Next, a confirmation test using the PHA method will be similarly explained. The confirmation test is performed more precisely on the test liquid determined to be positive or false positive in the screening, and two series of 8-stage (8-well) wells (71) are used for each test liquid. Similarly, one series of 8 columns each is used for positive and negative controls. To make the dilution ratio of the 8th stage 256, the first stage is 2 times diluted, and to make it 512 times, the first stage is diluted 4 times.

この場合、選定キー(27)・(28)を押して1〜4
及び5〜8段目の使用(LED(35)及び(36)点
灯)と、選定キー(30)を押して8段の指定(LED
(39)点灯)を行う。
In this case, press the selection keys (27) and (28) to
and use of the 5th to 8th stages (LEDs (35) and (36) are lit), and press the selection key (30) to specify the 8th stage (LED
(39) Lighting).

その他は、前記別間様にして2,4.・・・、256倍
或いは4,8.・・・512倍に希釈された25μtの
試料液の系列ができる。この全てについて、1列目は緩
衝液、2列目はHBeAg試薬を各25μ之ずつ加え、
10秒間程度震盪混和後37度で1時間インキュベート
する。続いて、HBeAg感作ヒツジ赤血球懸濁液を2
5μlずつ加え、10秒間程度震盪混和後37度で3時
間以上インキユベートシ、凝集像を観察する。判定は、
緩衝液を加えた系列とHBeAg試薬を加えた系列に於
ける凝集の阻止の有無を観察し、両者に器差がなければ
陰性、2管差以上有れば陽性、1管差の場合は再検して
再現性が有れば陽性とする。
Others are 2 and 4 according to the above. ..., 256 times or 4,8. ...A series of 25 μt sample solutions diluted 512 times is created. For all of this, add 25μ each of buffer in the first column and HBeAg reagent in the second column.
After shaking and mixing for about 10 seconds, incubate at 37 degrees for 1 hour. Subsequently, the HBeAg-sensitized sheep red blood cell suspension was
Add 5 μl each, mix by shaking for about 10 seconds, incubate at 37 degrees for 3 hours or more, and observe the aggregation image. The judgment is
Observe whether aggregation is inhibited in the series in which the buffer solution is added and in the series in which the HBeAg reagent is added. If there is no instrumental difference between the two, it is negative, if there is a difference of 2 or more tubes, it is positive, and if there is a difference of 1 tube, the test is repeated. If the test is reproducible, it is considered positive.

(変形例) 以上は、赤血球凝集反応を利用したPHA法によるHB
e抗体測定を例にとり説明したが、本発明は同様に赤血
球凝集反応に基づ<RPHA法によるHBe抗原の測定
や、HBc、HBd、HBsの抗原・抗体、瘍マーカー
(腫瘍特異蛋白質)の測定を行なうに際しても試薬を替
えて同様に用いることができるものである。更に、ラテ
ックスやマイクロパーティクルを用いる凝集反応を利用
した各種臨床検査にも利用できるものである。
(Modified example) The above is an HB method using the PHA method using red blood cell agglutination reaction.
Although the explanation has been given using e-antibody measurement as an example, the present invention is also applicable to measurement of HBe antigen by RPHA method, measurement of HBc, HBd, HBs antigens/antibodies, and tumor markers (tumor-specific proteins) based on hemagglutination reaction. It can be used in the same way by changing the reagents when carrying out this procedure. Furthermore, it can also be used in various clinical tests that utilize agglutination reactions using latex or microparticles.

また、少ない試料液の数で広い範囲の希釈倍率の測定を
するために3のn乗倍の希釈列を作ったり、より狭い希
釈倍率の範囲でより精密に測定するために2/3のn乗
倍の希釈系列を作ることも自在にできる。
In addition, in order to measure a wide range of dilution ratios with a small number of sample solutions, we can create a dilution series of 3 to the n power, or to measure more precisely in a narrower range of dilution ratios, we can make dilution series of 2/3 n times. You can also freely create a multiplication dilution series.

装置としては、スライドベース部(1)に被検液入れ更
には感作血球試薬入れを載置し、これらを同じノズル(
13)でウェル(71)に分注するようにしてもよい。
As for the device, a sample liquid container and a sensitized blood cell reagent container are placed on the slide base (1), and these are connected to the same nozzle (
13) may be dispensed into the wells (71).

また実施例の場合、ノズル(13)はノズルチップを交
換するディスポーザルタイプのものであり、検体数が少
ない場合チップをセントしないでおくこともできる。勿
論、固定式ノズルでもよい。ノズル(I3)の駆動は、
ノズルホルダー(IIO及びノズルアーム(I5)をノ
ズル(13)ごとに設け、個々に上下動させる構成を採
ってもよい。
Further, in the case of the embodiment, the nozzle (13) is a disposable type in which the nozzle tip is replaced, and if the number of specimens is small, the tip can be left unused. Of course, a fixed nozzle may also be used. The drive of the nozzle (I3) is as follows:
A nozzle holder (IIO) and a nozzle arm (I5) may be provided for each nozzle (13) and may be moved up and down individually.

〔効果〕〔effect〕

以上詳述したように本発明方法は、抗原・抗体反応を利
用した分析に用いる段階的に希釈した試料液の系列を、
1本のノズルを用いて調整するものである。従って、希
釈液の吸入・吐出、被検液との攪拌混合による希釈、採
取等が同一のノズルで同−量出し入れされるので、従来
法のようにマイクロピペットとダイリュータ−を用いる
ものに比して個人差、器差がなく、極めて正確な測定を
担保する。また吸引・吐出をプランジャーポンプ等で行
なうので、希釈液や被検液の採取、混合割合は自由に選
定でき、自由度が増す。更にダイリュータ−のように手
入れする必要もなく、作業効率が大幅に向上する。また
、ダイリュータ−を用いる攪拌のようにマイクロプレー
トのウェル内壁を疵付けることによる反応促進や試料液
の飛散による誤差もない等極めて優れたものである。
As described in detail above, the method of the present invention involves the use of a series of stepwise diluted sample solutions used for analysis using antigen-antibody reactions.
Adjustment is performed using one nozzle. Therefore, the same amount of inhalation and ejection of the diluted liquid, dilution by stirring and mixing with the test liquid, collection, etc., is carried out using the same nozzle, compared to the conventional method that uses a micropipette and diluter. This ensures extremely accurate measurements with no individual or instrumental differences. In addition, since suction and discharge are performed using a plunger pump or the like, the collection and mixing ratio of the diluent and test liquid can be freely selected, increasing the degree of freedom. Furthermore, there is no need to maintain it like a diluter, which greatly improves work efficiency. Furthermore, unlike stirring using a diluter, this method is extremely superior in that it does not accelerate the reaction by scratching the inner walls of the wells of the microplate and does not cause errors due to scattering of the sample liquid.

本発明装置は上記方法を具現化したもので、構造が極め
て簡単でありながら緩衝液の分注、被検液との攪拌・混
合、希釈を容易・正確且つ迅速に行なうものである。
The device of the present invention is an embodiment of the above method, and has an extremely simple structure, yet can easily, accurately, and quickly perform dispensing of a buffer solution, stirring/mixing with a test solution, and dilution.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図乃至第3図は本発明装置の一例を示し、第1図は
主要部の概略正面図、第2図はブロック図、第3図は流
路図である。また第4図はマイクロプレートの平面図、
第5図はダイリュータ−の斜視図である。 1・・・・・・スライドベース部 2・・・・・・ノズル部 3・・・・・・吸排ポンプ部 4・・・・・・操作部 5・・・・・・表示部 6・・・・・・記憶・制御部 7・・・・・・マイクロプレート 71・・・ウェル 8・・・・・・緩衝液容器 81・・・緩衝液 9・・・・・・スライドベース 13・・・・・・ノズル 19・・・・・・プランジャーポンプ 特 許 出 願 人  国際試薬株式会社特 許 出 
願 人  テラメックス株式会社第30 第4図 第5図
1 to 3 show an example of the apparatus of the present invention, in which FIG. 1 is a schematic front view of the main parts, FIG. 2 is a block diagram, and FIG. 3 is a flow path diagram. Figure 4 is a plan view of the microplate.
FIG. 5 is a perspective view of the diluter. 1...Slide base part 2...Nozzle part 3...Suction/exhaust pump part 4...Operation part 5...Display part 6... ...Storage/control unit 7...Microplate 71...Well 8...Buffer container 81...Buffer solution 9...Slide base 13... ... Nozzle 19 ... Plunger pump patent applicant Kokusai Reagent Co., Ltd. Patent issuer
Applicant Teramex Co., Ltd. No. 30 Figure 4 Figure 5

Claims (1)

【特許請求の範囲】 1、吸排ポンプに連結されるノズルでマイクロプレート
の各列の必要個数のウェルに夫々所定量の希釈液を分注
した後、該ノズル或いは他の手段で各列の第一ウェルに
所定量の被検液を分注し続いて該ノズルで数回吸排を繰
り返すことにより希釈液と被検液の攪拌混合を行い、次
いで該混合液の所定量を吸引して第二ウェルに注入し同
様に攪拌混合することにより希釈し、以下同様に各ウェ
ルについて順次吸入・混合・希釈を行なって希釈系列を
作ることを特徴とする分析用試料液の調製方法。 2、マイクロプレートと共に希釈液等の容器を載置して
所定位置間を間欠移動させるスライドベース部と、液体
の吸引・吐出によりマイクロプレートの各ウェルに各液
の分注と攪拌・希釈を行なうノズル部と、ノズルに吸引
・吐出させる吸排ポンプ部と、各工程の作動指示や項目
選択のためのキーを備えた操作部と、操作部からの入力
信号に基づき表示部に確認表示を出力するとともに該指
示により各部に作動指令を出力する記憶・制御部とから
構成されることを特徴とする分析用試料液の調製装置。
[Claims] 1. After dispensing a predetermined amount of diluent into the required number of wells in each row of the microplate using a nozzle connected to a suction pump, the nozzle or other means is used to dispense a predetermined amount of diluent into the required number of wells in each row of the microplate. Dispense a predetermined amount of the test liquid into one well, then repeat suction and discharge several times with the nozzle to stir and mix the diluted liquid and test liquid, and then aspirate a predetermined amount of the mixed liquid into the second well. A method for preparing a sample solution for analysis, characterized by diluting it by injecting it into a well and stirring and mixing in the same manner, and subsequently inhaling, mixing and diluting each well in sequence to create a dilution series. 2. A slide base part that places a container for diluting solution etc. together with the microplate and moves it intermittently between predetermined positions, and dispenses, stirs, and dilutes each solution into each well of the microplate by suctioning and discharging the liquid. A nozzle unit, a suction pump unit that causes the nozzle to suck and discharge, an operation unit that has keys for operating instructions for each process and selecting items, and outputs a confirmation message to the display unit based on input signals from the operation unit. 1. A device for preparing a sample liquid for analysis, comprising: a storage/control section that outputs operation commands to various sections according to the instructions;
JP20701086A 1986-09-03 1986-09-03 Method and apparatus for preparing sample liquid for analysis Pending JPS6361954A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20701086A JPS6361954A (en) 1986-09-03 1986-09-03 Method and apparatus for preparing sample liquid for analysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20701086A JPS6361954A (en) 1986-09-03 1986-09-03 Method and apparatus for preparing sample liquid for analysis

Publications (1)

Publication Number Publication Date
JPS6361954A true JPS6361954A (en) 1988-03-18

Family

ID=16532697

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20701086A Pending JPS6361954A (en) 1986-09-03 1986-09-03 Method and apparatus for preparing sample liquid for analysis

Country Status (1)

Country Link
JP (1) JPS6361954A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007495A1 (en) * 1991-10-08 1993-04-15 Aloka Co., Ltd. Method of diluting highly viscous liquid
JP2004325398A (en) * 2003-04-28 2004-11-18 Hitachi Software Eng Co Ltd Needle for continuous suction, and continuous suction device
JPWO2011108454A1 (en) * 2010-03-05 2013-06-27 コニカミノルタ株式会社 Cell detection method and cell detection system

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5240193B2 (en) * 1974-03-08 1977-10-11
JPS5451756A (en) * 1977-09-30 1979-04-23 Hitachi Ltd Control method for test unit
JPS5761953A (en) * 1980-09-30 1982-04-14 Shimadzu Corp Continuous absorption method for sample for flow cell of various kind of analysis and measuring instrument
JPS5779451A (en) * 1981-05-09 1982-05-18 Olympus Optical Co Ltd Sample dispenser used for analysis based on amynological agglutination reaction
JPS57186172A (en) * 1981-05-12 1982-11-16 Olympus Optical Co Ltd Condition establishing method for automatic analyzer
JPS5885168A (en) * 1981-11-16 1983-05-21 Toshiba Corp Automatic chemical analyzer

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5240193B2 (en) * 1974-03-08 1977-10-11
JPS5451756A (en) * 1977-09-30 1979-04-23 Hitachi Ltd Control method for test unit
JPS5761953A (en) * 1980-09-30 1982-04-14 Shimadzu Corp Continuous absorption method for sample for flow cell of various kind of analysis and measuring instrument
JPS5779451A (en) * 1981-05-09 1982-05-18 Olympus Optical Co Ltd Sample dispenser used for analysis based on amynological agglutination reaction
JPS57186172A (en) * 1981-05-12 1982-11-16 Olympus Optical Co Ltd Condition establishing method for automatic analyzer
JPS5885168A (en) * 1981-11-16 1983-05-21 Toshiba Corp Automatic chemical analyzer

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007495A1 (en) * 1991-10-08 1993-04-15 Aloka Co., Ltd. Method of diluting highly viscous liquid
JP2004325398A (en) * 2003-04-28 2004-11-18 Hitachi Software Eng Co Ltd Needle for continuous suction, and continuous suction device
JPWO2011108454A1 (en) * 2010-03-05 2013-06-27 コニカミノルタ株式会社 Cell detection method and cell detection system
JP5716738B2 (en) * 2010-03-05 2015-05-13 コニカミノルタ株式会社 Cell detection method and cell detection system

Similar Documents

Publication Publication Date Title
JP4178169B2 (en) Improved siphon to improve measurement accuracy
US11162962B2 (en) Automatic analysis device and sample analysis method
WO2018126773A1 (en) Automatic analyzer and sample analysis method
JP3682302B2 (en) Method and apparatus for controlling magnetic particles by dispenser
US5470534A (en) Analytical system useful in diagnosis of the condition of a disease
JP3453572B2 (en) Automatic continuous random access analysis system and its components
EP0089346B1 (en) Automated immunoassay system
JP2539512B2 (en) Multi-item analyzer and method for operating the analyzer
CN106226541B (en) A kind of automatic clinical chemistry analyzer of novel low cross contamination
JPS63259468A (en) Automatic patient sample analyzer
CN214953581U (en) Biological sample joint inspection equipment
CN108732135A (en) A kind of blood cell and analysis of protein device
JP3298332B2 (en) Biological sample analysis system
CN108663303A (en) A kind of blood analyser
CN114556082A (en) Sample analyzer and sample analyzing method
JP3659164B2 (en) Automatic analyzer
EP4012411A1 (en) Magnetic particle luminescence micro-fluidic chip for multi-marker detection, and detection device
CN110873704A (en) Liquid path system of sample analyzer, and sample analyzing method
JPS62228952A (en) Suction discharge method for automatic chemical analyzer
JPH04115136A (en) Particle measuring apparatus
JPS6361954A (en) Method and apparatus for preparing sample liquid for analysis
EP0336309A2 (en) A selective or sequential access analyzer for clinico-chemical analyses and for immunological tests
JP2000121650A (en) Automatic chemical analyzer
JP2000046843A (en) Automatic chemical analysis device
JPH11304799A (en) Reagent sampling shortage detection mechanism in whole blood globule immunity measuring device